Volume 17 (2022)
Volume 16 (2021)
Volume 15 (2020)
Volume 14 (2019)
Volume 13 (2018)
Volume 12 (2017)
Volume 11 (2016)
Volume 10 (2015)
Volume 9 (2014)
Volume 8 (2013)
Volume 7 (2012)
Volume 6 (2011)
Volume 5 (2010)
Volume 4 (2009)
Volume 3 (2008)
Volume 2 (2007)
Volume 1 (2006)
Pulmonary Pathology
The Frequency of Epidermal Growth Factor Receptor (EGFR) Mutation in Patients with Lung Adenocarcinoma Referred to a Lung Diseases Hospital; A Cross-Sectional Study from Iran

Sotoudeh Mohammadi; Mitra Rezaei; Fatemeh Shojaeian; Mihan Pourabdollah; Leila Mohammadi Ziazi; Sharareh Seifi; Atousa Doroodinia; Babak Salimi; Adnan Khosravi; Mohammad Amin Farhangnasab

Volume 17, Issue 2 , April 2022, , Pages 159-165

http://dx.doi.org/10.30699/ijp.2022.533427.2673

Abstract
  Background & Objective: Various studies showed the use  of epidermal growth factor receptors (EGFRs) gene mutations in the therapeutic plan of patients with advanced lung cancer. This study aimed to investigate the frequency and types of EGFR gene mutations among Iranian patients with lung adenocarcinoma ...  Read More

Molecular Pathology
Epidermal Growth Factor Receptor (EGFR) Gene Mutation Analysis in Adenocarcinoma of Lung, the First Report from Iran

Sahand Mohammadzadeh; Zahra Jowkar; Mitra Mirzaee; Bita Geramizadeh

Volume 14, Issue 1 , January 2019, , Pages 1-7

http://dx.doi.org/10.30699/ijp.14.1.1

Abstract
  Background and Objective: Epidermal growth factor receptor (EGFR) gene mutation, especially in exons 18 to 21, is an important predictor of the response rate of lung adenocarcinoma to tyrosine kinase inhibitors. There are variable reports from Asian and European countries, as well as North America, about ...  Read More

Lung Carcinoma Metastasis to the Distal Part of Index Finger: A Case Report

Mitra Heidarpour; Parvin Rajabi; Amin Eftekhari; Hamid Reza Ghasemibasir

Volume 1, Issue 4 , September 2006, , Pages 173-176

Abstract
  Although acrometastases are rare but clinically they are considered important. Their etiology is quite different from the metastases to other sites; bronchogenic carcinoma is by far the most frequent case. The prognosis is always similar to metastatic bronchial cancer with an average survival of three ...  Read More